Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Clinical trial NCT03572491 · COMPLETED
Trial details
- NCT number
- NCT03572491
- Sponsor
- Research Institute for Biological Safety Problems
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2018-05-21
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.